TESSITORE, ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 2.655
EU - Europa 1.971
AS - Asia 995
SA - Sud America 12
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 5.641
Nazione #
US - Stati Uniti d'America 2.648
IE - Irlanda 556
CN - Cina 421
IT - Italia 305
SE - Svezia 285
SG - Singapore 267
DE - Germania 260
TR - Turchia 244
UA - Ucraina 141
GB - Regno Unito 132
FR - Francia 122
FI - Finlandia 90
CZ - Repubblica Ceca 39
VN - Vietnam 29
IN - India 16
BE - Belgio 15
BR - Brasile 11
KR - Corea 5
AU - Australia 4
CA - Canada 4
ES - Italia 4
EU - Europa 3
NL - Olanda 3
RU - Federazione Russa 3
BD - Bangladesh 2
EE - Estonia 2
HU - Ungheria 2
IQ - Iraq 2
MY - Malesia 2
PL - Polonia 2
PT - Portogallo 2
RS - Serbia 2
AT - Austria 1
BG - Bulgaria 1
CH - Svizzera 1
CR - Costa Rica 1
EC - Ecuador 1
GR - Grecia 1
HK - Hong Kong 1
IL - Israele 1
IR - Iran 1
JP - Giappone 1
LT - Lituania 1
MX - Messico 1
NZ - Nuova Zelanda 1
PA - Panama 1
PK - Pakistan 1
RO - Romania 1
SA - Arabia Saudita 1
TH - Thailandia 1
Totale 5.641
Città #
Chandler 622
Jacksonville 565
Dublin 552
Boardman 227
Singapore 197
Izmir 133
Nanjing 98
Princeton 80
San Mateo 80
Lawrence 79
New York 74
Wilmington 74
Ann Arbor 73
Beijing 57
L'aquila 55
Bremen 45
Munich 44
Woodbridge 43
Brno 39
L’Aquila 37
Nanchang 35
Ashburn 34
Milan 30
Helsinki 29
Shenyang 29
Dong Ket 28
Los Angeles 25
Seattle 25
Tianjin 22
Verona 22
Aquila 20
Kitzingen 20
Shanghai 20
Brussels 15
Dallas 15
Des Moines 15
Jiaxing 15
Mountain View 15
Santa Clara 15
Hebei 14
Kunming 13
Zhengzhou 13
Philadelphia 12
Changsha 11
Norwalk 10
Rome 10
Dearborn 9
Pune 9
Guangzhou 8
Jinan 8
Ningbo 8
Redwood City 8
Houston 7
Lissone 7
Taizhou 7
Auburn Hills 6
Bari 6
Berlin 6
Bellante 5
Fremont 5
Menlo Park 5
Caserta 4
Changchun 4
Edinburgh 4
Hangzhou 4
Absecon 3
Clifton 3
Falls Church 3
Haikou 3
Hefei 3
Lanzhou 3
Pittsburgh 3
Pollenza 3
Redmond 3
Turin 3
Acerra 2
Baotou 2
Budapest 2
Cava de' Tirreni 2
Chicago 2
Chieti 2
Cleveland 2
Cugnoli 2
Düsseldorf 2
Frankfurt am Main 2
Giulianova 2
Jinhua 2
Madrid 2
Napoli 2
Nuremberg 2
Recale 2
Rho 2
Saint-Fons 2
Simi Valley 2
São Paulo 2
Tallinn 2
Torino 2
Venezia 2
Warsaw 2
Alta Floresta 1
Totale 3.885
Nome #
new bioinformatics approach to identify target genes for dysregulated micrornas in a chemically-induced hepatocarcinoma mouse model 127
Bioinformatics approach to predict target genes for dysregulated microRNAs in hepatocellular carcinoma: Study on a chemically-induced HCC mouse model 121
The prevalent KRAS exon 2 c.35 G > A mutation in metastatic colorectal cancer patients: a biomarker of worse prognosis and potential benefit of bevacizumab-containing intensive regimens? 119
Therapeutic Use of MicroRNAs in Cancer 106
Cancer secretome and inflammation: The bright and the dark sides of NF-kB 106
KRAS and Two Rare PI3KCA Mutations Coexisting in a Metastatic Colorectal Cancer Patient With Aggressive and Resistant Disease. 106
EFFECTS OF SAFFRON ON HEPATOCARCINOGENESIS PROCESS: A STUDY ON A MOUSE MODEL 103
Involvement of an arachidonic-acid-dependent pathway in the interferon-beta-mediated expression of C202 gene in Ehrlich-ascites-tumor cells 103
Prognostic significance of clinicopathological factors in early breast cancer: 20 years of follow-up in a single-center analysis. 101
Targeting the NF-κB pathway in prostate cancer: a promising therapeutic approach? 100
Neoadjuvant chemotherapy in breast cancer: a dose-dense schedule in real life and putative role of PIK3CA mutations. 100
ANALISI DEL miRNoma NELL’EPATOCARCINOMA INDOTTO DA DIETILNITROSAMINA 99
Development of hepatocellular cancer induced by long term low fat-high carbohydrate diet in a nafld/nash mouse model 92
Next-generation sequencing: Recent applications to the analysis of colorectal cancer 91
The Role of Circulating MicroRNAs as Biomarkers in NAFLD 91
MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice 90
TrkA alternative splicing: A regulated tumor-promoting switch in human neuroblastoma 89
mir-182 dysregulation in a diet-induced NAFLD-NASH-hepatocellular carcinoma mouse model 89
MIRNOME ANALYSIS IN THE PATHOGENESIS OF HEPATOCARCINOMA 83
two simulteneous and very uncommom pi3kca mutations in a liver metastasis from colorectal cancer patient with aggressive and resistant disease 83
development of hepatocellular cancer in a murine model of nonalcoholic steatohepatitis induced by use of low-fat/high carbohydrate diet 83
A KRAS and dual concomitant PI3KCA mutations in a metastatic colorectal cancer patient with aggressive and resistant disease 79
Characterization of a novel HLA-Cw*02 variant, Cw*0208, in a Caucasian individual 78
Angiotensin II stimulates intercellular adhesion molecule-1(ICAM1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo 78
Prognostic relevance of KRAS genotype and the prevalent C.35 G > a mutation in metastatic colorectal cancer (MCRC) patients fitting for intensive FIr-B/FOx triplet chemotherapy plus bevacizumab 78
crosstalk between nf-kb and shh pathways in prostate cancer 76
Serum biomarkers identification by mass spectrometry in high-mortality tumors. 75
Identification of the novel allele B*4427 and a confirmatory sequence (B*44022) 73
Can analysis of the molecular status of the p53 gene contribute to improving the therapeutic strategy for breast carcinoma? 71
New mutations and protein variants of NBSI are identified in cancer cell lines 70
Pharmacogenetics and clinical oncology: a new deal for personalized therapies 70
Two gamma-interferon-activation sites (GAS) on the promoter of the human intercellular adhesion molecule 1 (ICAM-1) gene are required for induction of transcription by IFN-gamma 70
MicroRNAs in the DNA Damage/Repair Network and Cancer 69
Prognostic relevance of PIK3CA mutations in breast cancer patients treated with primary dose-dense epirubicin/cyclophosphamide -> dose-dense docetaxel 69
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study 69
Novel P53 mutations detected by FAMA in colorectal cancers 68
KCTD11 tumor suppressor gene expression is reduced in prostate adenocarcinoma 68
MICA∗078: A novel allele identified in a moroccan individual affected by celiac disease. 67
The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages. 67
the role of kctd11 tumor suppressor gene in prostate cancer 66
A NEW ALLELE, MICA*078, IDENTIFIED IN A MOROCCAN INDIVIDUAL WITH CELIAC DISEASE 65
Reverse-phase protein microarray highlights HER2 signaling activation in immunohistochemistry/FISH/HER2-negative breast cancers. 65
High sensitivity of detectionof TP53 somatic mutations by fluorescence-assisted mismatch analysis 65
Identification of the uncommon allele HLA-A*7403 in a Caucasian renal transplant cadaveric donor: Extension of the exon 4 sequence 64
Identification of a novel HLA-DRB1*11 allele: DRB1*1152 63
Effective treatment of a platinum-resistant cutaneous squamous cell carcinoma case by EGFR pathway inhibition 63
Human leukocyte antigen-A, -B, and -Cw polymorphism in a Berber population from North Morocco using sequence-based typing 62
MiRNome analysis in high-fat diet-induced hepatocarcinoma. 62
Smart hydrogel particles: Biomarker harvesting: One-step affinity purification, size exclusion, and protection against degradation 61
Identification of a novel allele variant of HLA-B*57 in a Caucasian Moroccan individual: B*57032 60
Emerging role of isomirs in cancer: State of the art and recent advances 60
Prognostic value of p53 molecular status in high-risk primary breast cancer 59
Prognostic significance of P53 mutations in high risk node positive breast cancer patients 59
Identification of a novel HLA-A*02 allele, A*027401* 59
Increased CD1D polymorphism: identification of two novel alleles, CD1D*03 and *04, in individuals from Morocco. 58
Role of bcr-abl in the regulation and inhibition of apoptosis 58
Efficacy and tolerability of Everolimus-Exemestane combination therapy in metastatic breast cancer patients: experience in Real Life 58
Analytical scanning of p53 mutations by FAMA (fluorescence assisted mismatch analysis) in colorectal cancers and preliminary prognostic findings. 57
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling 57
Concurrent RAS and RAS/BRAF V600E variants in colorectal cancer: more frequent than expected? 54
A Simplified Genomic Profiling Approach Predicts Outcome in Metastatic Colorectal Cancer. 53
An initial characterization of the serum phosphoproteome. 53
Prenatal diagnosis of a rhodopsin mutation using chemical cleavage of the mismatch 52
Low Radiation Environment Switches the Overgrowth-Induced Cell Apoptosis Toward Autophagy 52
Ultrasound-based method for the identification of novel microrna biomarkers in prostate cancer 52
Role of exosomal microRNAs in cancer therapy and drug resistance mechanisms: focus on hepatocellular carcinoma 51
Serum low-molecular-weight protein fractionation for biomarker discovery 51
SMO-M2 mutation does not support cell-autonomous Hedgehog activity in cerebellar granule cell precursors 51
Applications of Next Generation Sequencing to the Analysis of Familial Breast/Ovarian Cancer 51
MicroRNAs Expression in Response to rhNGF in Epithelial Corneal Cells: Focus on Neurotrophin Signaling Pathway 51
Mass spectrometry driven discovery proteomics of serum from mice with human ovarian cancer resulted in identification of a potential cancer-origin biomarker that correlates with peritoneal tumor burden. 49
MRE11 inhibition highlights a replication stress-dependent vulnerability of MYCN-driven tumors 49
IDENTIFICATION OF TWO NOVEL ALLELES, CD1D*03 AND*04, IN INDIVIDUALS FROM MOROCCO 48
Circulating micrornas as prognostic and therapeutic biomarkers in breast cancer molecular subtypes 47
Longitudinal monitoring of mRNA levels of regulatory T cell biomarkers by using non-invasive strategies to predict outcome in renal transplantation 42
Codon optimization by 0-1 linear programming 41
Long-term abuse of a high-carbohydrate diet is as harmful as a high-fat diet for development and progression of liver injury in a mouse model of NAFLD/NASH 40
Anthracycline-Free Neoadjuvant Treatment in Patients with HER2-Positive Breast Cancer: Real-Life Use of Pertuzumab, Trastuzumab and Taxanes Association with an Exploratory Analysis of PIK3CA Mutational Status. 39
null 38
A European observational study to evaluate the safety and the effectiveness of safinamide in routine clinical practice: The SynapSES trial 38
Neuroprotective effects of human amniotic fluid stem cells-derived secretome in an ischemia/reperfusion model 37
null 35
Detection of NBS1 (Nibrin) mutations in breast and ovarian cancer 35
MicroRNAs expression analysis in high-fat diet induced NAFLD-NASH-HCC progression: study on C57BL/6J mice 30
Classification of tumor types using XGBoost machine learning model: a vector space transformation of genomic alterations 28
MiR-182-5p Is Upregulated in Hepatic Tissues from a Diet-Induced NAFLD/NASH/HCC C57BL/6J Mouse Model and Modulates Cyld and Foxo1 Expression 26
Mitotic phosphorylation of Tau/MAPT modulates cell cycle progression in prostate cancer cells 18
MicroRNA profiling in women with migraine: effects of CGRP-targeting treatment 17
A method to comprehensively identify germline SNVs, INDELs and CNVs from whole exome sequencing data of BRCA1/2 negative breast cancer patients 15
Role of Breast Cancer Risk Estimation Models to Identify Women Eligible for Genetic Testing and Risk-Reducing Surgery 13
Role of the Molecular Tumor Board for the Personalized Treatment of Patients with Metastatic Breast Cancer: A Focus on the State of the Art in Italy 10
Takotsubo Syndrome during Pertuzumab and Trastuzumab Therapy for HER2-Positive Metastatic Breast Cancer 9
Totale 5.873
Categoria #
all - tutte 25.221
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.221


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020412 0 0 0 0 2 77 129 11 85 26 5 77
2020/2021756 26 75 6 75 89 36 99 39 83 39 129 60
2021/2022514 35 25 128 43 21 5 9 28 35 9 33 143
2022/20231.684 106 125 30 213 167 184 2 86 682 11 56 22
2023/2024474 46 26 19 41 31 118 2 45 0 18 29 99
2024/2025550 83 62 228 103 74 0 0 0 0 0 0 0
Totale 5.873